AI System to Help Lymphoma Patients Take Oral Medications
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests an artificial intelligence (AI) system designed to predict and help prevent medication non-compliance—meaning skipped or missed doses—in lymphoma patients taking oral (by-mouth) therapies. The goal is to catch problems early and support patients in taking their medications as prescribed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are being treated for non-Hodgkin lymphoma (a type of blood cancer)
- You are receiving care at the Grand Hôpital de Charleroi in Belgium
- You are taking oral medication (pills or liquid) as part of your lymphoma treatment
- You are able to understand the study and give your permission to participate
- Your treatment must start on or after November 2025
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using artificial intelligence to guide treatment after one round of chemotherapy works better than standard treatment for a type of blood cancer called LBCL. You'll receive initial chemotherapy, then be assigned to either an AI-guided treatment plan or standard chemotherapy based on how well you respond.
This trial tests if an AI-powered system can help monitor and manage side effects during chemotherapy for breast or colorectal cancer. If you are starting chemotherapy and can report your symptoms, this study may offer extra support.
This trial tests if an artificial intelligence (AI) program can help people with blood cancer learn about their condition and treatment. The goal is to see if AI-assisted education improves their understanding and care.
This trial tests a non-invasive, AI-based monitoring program for people with solid tumors. It aims to help track how you’re doing during or after curative-intent treatment, using information collected without extra procedures.
This study tests an AI-powered program that helps doctors manage cancer patients who also have other health conditions. You may be able to join if you are starting or currently receiving cancer treatment and can use a smart device.
This trial tests whether an AI-guided treatment plan works better than a standard drug combination for older adults with a type of lymphoma. It is for people who are age 70 or older, have not had treatment before, and are considered less fit for strong chemotherapy.
Hear when a new Care Coordination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.